These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 27837787)
1. Centralized access to cancer registries. Deapen D Ann Epidemiol; 2016 Nov; 26(11):754-756. PubMed ID: 27837787 [TBL] [Abstract][Full Text] [Related]
2. Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safety. Pinheiro SP; Rivera DR; Graham DJ; Freedman AN; Major JM; Penberthy L; Levenson M; Bradley MC; Wong HL; Ouellet-Hellstrom R Ann Epidemiol; 2016 Nov; 26(11):735-740. PubMed ID: 27663208 [TBL] [Abstract][Full Text] [Related]
3. Innovative postmarket device evaluation using a quality registry to monitor thoracic endovascular aortic repair in the treatment of aortic dissection. Beck AW; Lombardi JV; Abel DB; Morales JP; Marinac-Dabic D; Wang G; Azizzadeh A; Kern J; Fillinger M; White R; Cronenwett JL; Cambria RP; J Vasc Surg; 2017 May; 65(5):1280-1286. PubMed ID: 28216355 [TBL] [Abstract][Full Text] [Related]
5. A systematic assessment of key design and performance characteristics of drug exposure registries requested by the U.S. Food and Drug Administration. Zhao Y; Pinnow E; Major JM Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):299-306. PubMed ID: 29349833 [TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
7. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment. Roller ST; Pippins RR; Ngai JW Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646 [TBL] [Abstract][Full Text] [Related]
8. The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8Â years. Gilsenan A; Harding A; Kellier-Steele N; Harris D; Midkiff K; Andrews E Osteoporos Int; 2018 Oct; 29(10):2335-2343. PubMed ID: 29978254 [TBL] [Abstract][Full Text] [Related]
9. The US Food and Drug Administration's expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements. Wallach JD; Ross JS; Naci H Clin Trials; 2018 Jun; 15(3):219-229. PubMed ID: 29871509 [TBL] [Abstract][Full Text] [Related]
11. Postmarketing Modifications of Drug Labels for Cancer Drugs Approved by the US Food and Drug Administration Between 2006 and 2016 With and Without Supporting Randomized Controlled Trials. Shepshelovich D; Tibau A; Goldvaser H; Molto C; Ocana A; Seruga B; Amir E J Clin Oncol; 2018 Jun; 36(18):1798-1804. PubMed ID: 29641296 [TBL] [Abstract][Full Text] [Related]
12. Pediatric registries at the Food and Drug Administration: design aspects that increase their likelihood of success. Winiecki SK; Tejero-Taldo MI; Avant D; Murphy D; McMahon AW Pharmacoepidemiol Drug Saf; 2016 May; 25(5):602-5. PubMed ID: 26687996 [TBL] [Abstract][Full Text] [Related]
13. Comparison of adverse event and device problem rates for transcatheter aortic valve replacement and Mitraclip procedures as reported by the Transcatheter Valve Therapy Registry and the Food and Drug Administration postmarket surveillance data. Galper BZ; Beery DE; Leighton G; Englander LL Am Heart J; 2018 Apr; 198():64-74. PubMed ID: 29653650 [TBL] [Abstract][Full Text] [Related]
15. Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis. Wallach JD; Egilman AC; Dhruva SS; McCarthy ME; Miller JE; Woloshin S; Schwartz LM; Ross JS BMJ; 2018 May; 361():k2031. PubMed ID: 29794072 [TBL] [Abstract][Full Text] [Related]
16. American Society of Clinical Oncology policy statement: oversight of clinical research. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281 [TBL] [Abstract][Full Text] [Related]
17. Medical device postapproval safety monitoring: where does the United States stand? Rajan PV; Kramer DB; Kesselheim AS Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):124-31. PubMed ID: 25563662 [No Abstract] [Full Text] [Related]
19. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. Weir HK; Thun MJ; Hankey BF; Ries LA; Howe HL; Wingo PA; Jemal A; Ward E; Anderson RN; Edwards BK J Natl Cancer Inst; 2003 Sep; 95(17):1276-99. PubMed ID: 12953083 [TBL] [Abstract][Full Text] [Related]